ATE181916T1 - Verfahren zur herstellung von hiv protease inhibitor ausgehend von (2s)-4-picolyl-2- piperazin-t-butylcarboxamid - Google Patents

Verfahren zur herstellung von hiv protease inhibitor ausgehend von (2s)-4-picolyl-2- piperazin-t-butylcarboxamid

Info

Publication number
ATE181916T1
ATE181916T1 AT96908523T AT96908523T ATE181916T1 AT E181916 T1 ATE181916 T1 AT E181916T1 AT 96908523 T AT96908523 T AT 96908523T AT 96908523 T AT96908523 T AT 96908523T AT E181916 T1 ATE181916 T1 AT E181916T1
Authority
AT
Austria
Prior art keywords
butylcarboxamide
picolyl
piperazine
protease inhibitor
hiv protease
Prior art date
Application number
AT96908523T
Other languages
English (en)
Inventor
David Askin
Kan K Eng
Paul Reider
Ralph P Volante
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE181916T1 publication Critical patent/ATE181916T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
AT96908523T 1995-03-15 1996-03-11 Verfahren zur herstellung von hiv protease inhibitor ausgehend von (2s)-4-picolyl-2- piperazin-t-butylcarboxamid ATE181916T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/404,798 US5618937A (en) 1995-03-15 1995-03-15 Process to make HIV protease inhibitor from (2S)-4-picolyl-2-piperazine-t-butylcarboxamide

Publications (1)

Publication Number Publication Date
ATE181916T1 true ATE181916T1 (de) 1999-07-15

Family

ID=23601087

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96908523T ATE181916T1 (de) 1995-03-15 1996-03-11 Verfahren zur herstellung von hiv protease inhibitor ausgehend von (2s)-4-picolyl-2- piperazin-t-butylcarboxamid

Country Status (16)

Country Link
US (1) US5618937A (de)
EP (1) EP0815101B1 (de)
CN (1) CN1100054C (de)
AR (1) AR002712A1 (de)
AT (1) ATE181916T1 (de)
AU (1) AU5173896A (de)
BR (1) BR9607376A (de)
CZ (1) CZ292549B6 (de)
DE (1) DE69603163D1 (de)
EA (1) EA000178B1 (de)
HR (1) HRP960114B1 (de)
SK (1) SK282021B6 (de)
TW (1) TW332205B (de)
UA (1) UA49826C2 (de)
WO (1) WO1996028439A1 (de)
YU (1) YU15496A (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700364A (en) * 1995-10-30 1997-12-23 Merck & Co., Inc. Electrochemical oxidation
NL1006305C2 (nl) * 1997-06-13 1998-12-15 Dsm Nv Werkwijze voor de bereiding van (1S,2R)-1-amino-2-indanol-(R,R)-tartraat methanol solvaat.
US7199240B2 (en) * 2002-12-11 2007-04-03 Merck & Co., Inc. Reductive alkylation of saturated cyclic amines
US10620330B2 (en) 2013-03-19 2020-04-14 Westerngeco L.L.C. Estimating translational data
CN110835405B (zh) * 2019-11-28 2020-09-15 安阳师范学院 用于肿瘤检测的高分子生物传感器及制备方法及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169952A (en) * 1991-07-02 1992-12-08 Merck & Co., Inc. Stereoselective production of hydroxyamide compounds from chiral α-amino epoxides
US5413999A (en) * 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
ES2112880T3 (es) * 1991-11-08 1998-04-16 Merck & Co Inc Inhibidores de la proteasa de vih utiles para el tratamiento del sida.
MX9308016A (es) * 1992-12-22 1994-08-31 Lilly Co Eli Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene.
US5463067A (en) * 1993-07-16 1995-10-31 Merck & Co., Inc. Process for making HIV protease inhibitors
TW472047B (en) * 1994-02-04 2002-01-11 Merck & Co Inc Process for making HIV protease inhibitors
US5420353A (en) * 1994-03-11 1995-05-30 Merck & Co., Inc. Regiospecific process to make cis-1-amino-2-alkanol from epoxide
US5449830A (en) * 1994-03-11 1995-09-12 Marck & Co., Inc. Regiospecific processes to make CIS-1-Amino-2-Alkanol from Diol or Halohydrin

Also Published As

Publication number Publication date
CN1183779A (zh) 1998-06-03
AR002712A1 (es) 1998-04-29
EA199700235A1 (ru) 1998-04-30
CZ286097A3 (cs) 1998-02-18
SK282021B6 (sk) 2001-10-08
HRP960114A2 (en) 1997-10-31
TW332205B (en) 1998-05-21
WO1996028439A1 (en) 1996-09-19
AU5173896A (en) 1996-10-02
BR9607376A (pt) 1997-12-30
EA000178B1 (ru) 1998-12-24
EP0815101B1 (de) 1999-07-07
SK122597A3 (en) 1998-02-04
EP0815101A1 (de) 1998-01-07
DE69603163D1 (de) 1999-08-12
US5618937A (en) 1997-04-08
YU15496A (sh) 1999-03-04
CN1100054C (zh) 2003-01-29
HRP960114B1 (en) 2000-02-29
CZ292549B6 (cs) 2003-10-15
UA49826C2 (uk) 2002-10-15

Similar Documents

Publication Publication Date Title
ATE243211T1 (de) Verfahren zur herstellung von dihalogenazolopyrimidinen
DE69603255D1 (de) Verfahren zur modifizierung von oberflächen
DE69516188D1 (de) Verfahren zur herstellung von therephthalsäure
DE59604922D1 (de) Verfahren zur herstellung von polyalkoholen
DE69604277D1 (de) Verfahren zur herstellung von nootkaton
DE69816440D1 (de) Verfahren zur herstellung von flurbiprofen-lutschtabletten
DE69618646D1 (de) Verfahren zur herstellung von peroxiden
DE69808037D1 (de) Verfahren zur herstellung von hydroperoxiden
DE69612745D1 (de) Verfahren zur herstellung von hydroxyalkylamiden
ATE294169T1 (de) Verfahren zur herstellung von 8-methoxy- chinoloncarbonsäuren
DE69628421D1 (de) Verfahren zur herstellung von tetraazacycloalkanen.
DE69615660D1 (de) Verfahren zur herstellung von lactamen
DE59601604D1 (de) Verfahren zur herstellung von n-aryl- und n-hetarylhydroxylaminen
ATE267812T1 (de) Verfahren zur herstellung von n-substituierten 3- hydroxypyrazolen
ATE303134T1 (de) Verfahren zur herstellung von flavano-lignan- zubereitungen
DE69614571D1 (de) Verfahren zur herstellung von lovastatin
DE69414253D1 (de) Verfahren zur herstellung von oximin
DE59601895D1 (de) Verfahren zur herstellung von butyrolactonen
DE69616322D1 (de) Verfahren zur herstellung von 3-isochromanonen
ATE207900T1 (de) Verfahren zur herstellung von ropivacainehydrochlorid-monohydrat
DE59401406D1 (de) Verfahren zur herstellung von naphtalocyaninen
DE69622692D1 (de) Verfahren zur herstellung von ungesättigten nitrilen
DE69608442D1 (de) Verfahren zur herstellung von 5-formylvelerionsäure
DE69615836D1 (de) Verfahren zur herstellung von boroxyd
ATE242772T1 (de) Verfahren zur herstellung von hiv-protease inhibitoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties